Xeris Biopharma Holdings, Inc.
XERS
$6.13
$0.111.74%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
4/30/2026
-
MarketBeat
Xeris Biopharma Holdings (XERS, $6.05) price moved above its 50-day Moving Average on April 24, 2026
4/25/2026
-
Tickeron - Technical Analysis
4/25/2026
-
Tickeron - Technical Analysis
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Rating of "Moderate Buy" from Analysts
4/24/2026
-
MarketBeat
4/23/2026
-
Business Wire
4/22/2026
-
Tickeron - Stocks
4/22/2026
-
Tickeron - Stocks
Xeris Biopharma Holdings (XERS, $6.37) price moved above its 50-day Moving Average on April 17, 2026
4/18/2026
-
Tickeron - Stocks
4/18/2026
-
Tickeron - Stocks
4/17/2026
-
MarketBeat
Xeris Biopharma Holdings (XERS, $6.19) price moved above its 50-day Moving Average on April 15, 2026
4/16/2026
-
Tickeron - Technical Analysis
4/13/2026
-
Simply Wall St
4/8/2026
-
MarketBeat
4/7/2026
-
Simply Wall St
4/4/2026
-
MarketBeat
4/3/2026
-
MarketBeat
4/3/2026
-
Business Wire
4/3/2026
-
MarketBeat
4/2/2026
-
MarketBeat
4/2/2026
-
Tickeron - Technical Analysis
4/2/2026
-
MarketBeat
4/1/2026
-
Tickeron - Stocks
3/31/2026
-
Tickeron - Stocks
3/30/2026
-
MarketBeat
3/27/2026
-
Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 2, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
844 445 5704
Address
1375 West Fulton Street
Chicago, IL 60607
Chicago, IL 60607
Country
Year Founded
Business Description
Sector
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It...
more